3,3'-diindolylmethane
- Generic Name
- 3,3'-diindolylmethane
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H14N2
- CAS Number
- 1968-05-4
- Unique Ingredient Identifier
- SSZ9HQT61Z
- Background
Diindolylmethane has been used in trials studying the prevention and treatment of SLE, Prostate Cancer, Cervical Dysplasia, Stage I Prostate Cancer, and Stage II Prostate Cancer, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Diindolylmethane in Preventing Cancer in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy, no Evidence of Disease
- Interventions
- Drug: diindolylmethaneOther: placeboOther: pharmacological studyOther: laboratory biomarker analysisOther: quality-of-life assessment
- First Posted Date
- 2008-11-04
- Last Posted Date
- 2016-12-29
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 20
- Registration Number
- NCT00784394
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer
Phase 1
Completed
- Conditions
- Stage I Prostate CancerStage II Prostate CancerAdenocarcinoma of the ProstateProstate Cancer
- Interventions
- Drug: diindolylmethaneDrug: placeboProcedure: therapeutic conventional surgeryOther: laboratory biomarker analysisOther: pharmacological study
- First Posted Date
- 2007-03-22
- Last Posted Date
- 2015-12-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 45
- Registration Number
- NCT00450229
- Locations
- 🇺🇸
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States
Diindolylmethane in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy, no Evidence of Disease
- Interventions
- First Posted Date
- 2006-10-26
- Last Posted Date
- 2016-12-29
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 14
- Registration Number
- NCT00392652
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath